June 26, 2024
IVIG Trial Recruitment is Closed
Octapharma/PACE Foundation IVIG Trial Update: 6-26-24 Read the Announcement from the PACE Foundation. Given the recent changes posted on ClinicalTrials.Gov, we wanted to update...
Monthly Archives:
June 2024
June 20, 2024
A totally new kid’: Parents push for coverage of controversial IV treatment for brain condition
Legislation in the Michigan House would require insurers to cover the treatment for children who suffer from a brain condition believed to be caused by...
June 3, 2024
Colorado PANS PANDAS Updates
HB24-1382 Bill Status: Read History Bill Language: Read Here Bill Summary To the extent the coverage is not in addition to the benefits provided pursuant to the health...
Antipsychotic medications associated with increased length of hospital stay in autoimmune encephalitis and multiple sclerosis: A retrospective study
Stephen Sai Folmsbee, Gavin Hui, Ye Yuan, Saurabh Gombar, May Han, Scheherazade Le,
Antipsychotic medications associated with increased length of hospital stay in autoimmune encephalitis and multiple sclerosis: A retrospective study, Journal of Clinical Neuroscience,
Volume 124, 2024, Pages 87-93, ISSN 0967-5868, https://doi.org/10.1016/j.jocn.2024.04.021.
-
Antipsychotic medications associated with worse hospital length-of-stay in autoimmune encephalitis and multiple sclerosis.
-
Typical antipsychotics associated with worse mortality, but decreased hospital length-of-stay, when compared to atypical antipsychotics in multiple sclerosis.
-
Antidepressant medications associated with increased hospital length-of-stay in multiple sclerosis.
-
Citalopram and fluoxetine were associated with worse hospital length-of-stay for those with multiple sclerosis when compared to other antidepressants.
-
Black patients with neuroinflammatory disorders were more likely to receive antipsychotics, but less likely to receive antidepressants.